Sera Prognostics
Sera Prognostics Hits Endpoints in Study of Biomarker Test for Preterm Birth Risk, Stops Enrollment
The decision follows a preplanned interim analysis and recommendation from a data safety monitoring board.
The decision follows a preplanned interim analysis and recommendation from a data safety monitoring board.